[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340975-105":59,"doc-detail-340975-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omic-dataset-of-patient-derived-tumor-organoids-of-neuroendocrine-neoplasms-data-note","Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms - Data Note","","Organoids serve as three-dimensional experimental models for capturing organ structure and function, and patient-derived tumor organoids (PDTOs) support precision medicine. This Data Note presents the first multi-omic dataset combining whole-genome sequencing (WGS) and RNA-seq for rare pulmonary neuroendocrine tumors, with additional neuroendocrine neoplasms including small intestine and large-cell subtypes. The release includes quality control, raw and processed data, analysis scripts, gene-expression and somatic variant calls, classifier training from tumor-only RNA-seq, and histopathology images.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omic-dataset-of-patient-derived-tumor-organoids-of-neuroendocrine-neoplasms-data-note/340975/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omic-dataset-of-patient-derived-tumor-organoids-of-neuroendocrine-neoplasms-data-note/340975.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the multi-omic dataset include for neuroendocrine tumor organoids?","Question",{"text":112,"@type":113},"It includes whole-genome sequencing (WGS) and RNA-seq for patient-derived tumor organoids, along with gene-expression data and somatic variant calls. Quality control, raw/processed data, and scripts for genomic analyses are provided.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which neuroendocrine tumor types and sample sizes are covered?",{"text":117,"@type":113},"The dataset covers rare pulmonary neuroendocrine tumors (n = 12), ileal neuroendocrine tumors (n = 6), and large-cell neuroendocrine carcinoma (n = 5). It also includes matched parental samples for the majority of samples and longitudinal PDTO sampling across time points.",{"name":119,"@type":110,"acceptedAnswer":120},"How are variants detected in tumor-only RNA-seq?",{"text":121,"@type":113},"The document describes using WGS somatic calls to train a random forest classifier to detect variants in tumor-only RNA-seq. Histopathology images used for medical diagnosis are also reported.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340975,1790694344,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","GigaScience, 2024, 13, 1–13 DOI: 10.1093/gigascience/giae008  \nData Note  \nMulti-omic dataset of patient-derived tumor organoidsof neuroendocrine neoplasms  \nNicolas Alcala 1 , *,†, Catherine Voegele 1 , Lise Mangiante 1,2 , Alexandra Sexton-Oates 1 , Hans Clevers 3,4 ,‡, Lynnette Fernandez-Cuesta 1 , Talya L. Dayton 3,4 ,†,§ , and Matthieu Foll 1 , *,†  \n1 Rare Cancers Genomics Team (RCG), Genomic Epidemiology Branch (GEM), International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon 69008, France  \n2 Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA  \n3 Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT Utrecht, The Netherlands  \n4 Oncode Institute, Hubrecht Institute, 3584 CT Utrecht, The Netherlands  \n∗ Correspondence address. Nicolas Alcala, 25 avenue Tony Garnier CS 90627 69366 Lyon Cedex 07, France. E-mail: [alcalan@iarc.who.int](alcalan@iarc.who.int), and Matthieu Foll, 25  \navenue Tony Garnier CS 90627 69366 Lyon Cedex 07, France E-mail: [follm@iarc.who.int](follm@iarc.who.int)[ ](follm@iarc.who.int)†These authors jointly supervised this work.  \n‡ Current address: Roche Pharmaceutical Research and Early Development, Basel, Switzerland.  \n§ Current address: European Molecular Biology Laboratory (EMBL) Barcelona, Barcelona, Spain.  \nAbstract  \nBackground: Organoids are 3-dimensional experimental models that summarize the anatomical and functional structure of an organ. Although a promising experimental model for precision medicine, patient-derived tumor organoids (PDTOs) have currently been developed only for a fraction of tumor types.  \nResults: We have generated the first multi-omic dataset (whole-genome sequencing [WGS] and RNA-sequencing [RNA-seq]) of PDTOs from the rare and understudied pulmonary neuroendocrine tumors (n = 12; 6 grade 1, 6 grade 2) and provide data from other rare neuroendocrine neoplasms: small intestine (ileal) neuroendocrine tumors (n = 6; 2 grade 1 and 4 grade 2) and large-cell neuroendocrine carcinoma (n = 5; 1 pancreatic and 4 pulmonary). This dataset includes a matched sample from the parental sample (primary tumor or metastasis) for a majority of samples (21/23) and longitudinal sampling of the PDTOs (1 to 2 time points), for a total of n = 47 RNA-seq and n = 33 WGS. We here provide quality control for each technique and the raw and processed data as well as all scripts for genomic analyses to ensure an optimal reuse of the data. In addition, we report gene expression data and somatic small variant calls and describe how they were generated, in particular how we used WGS somatic calls to train a random forest classifier to detect variants in tumor-only RNA-seq. We also report all histopathological images used for medical diagnosis: hematoxylin and eosin–stained slides, brightfield images, and immunohistochemistry images of protein markers of clinical relevance.  \nConclusions: This dataset will be critical to future studies relying on this PDTO biobank, such as drug screens for novel therapies and experiments investigating the mechanisms of carcinogenesis in these understudied diseases.  \nKeywords: organoid, cancer, neuroendocrine neoplasm, genomics, transcriptomics, quality control  \nKey points:  \n􀀂 Tumor-derived organoids are revolutionary experimental resources to test biological hypotheses and treatment options.  \n􀀂 We have generated the first multi-omic dataset for neuroendocrine tumor organoids ofthe lung and for the rare neuroendocrine tumors ofthe pancreas and small intestine (ileum) .  \nData Description  \nContext  \nOrganoids are 3-dimensional experimental models that summarize the anatomical and functional structure of an organ [1 , 2] . Organoids are revolutionizing fundamental and medical research by allowing us to recapitulate human physiology better than an-  \nimal models, as well as developmental biology contrary to traditional cell cultures [2] . Patient-derived tumo","cbCaiaPNueqmTiK0","https://ap.wps.com/l/cbCaiaPNueqmTiK0","pdf",2330233,13,"English","# Abstract\n## Background\n## Results\n## Conclusions\n## Keywords\n# Key points\n# Data Description\n## Context","[{\"question\":\"What does the multi-omic dataset include for neuroendocrine tumor organoids?\",\"answer\":\"It includes whole-genome sequencing (WGS) and RNA-seq for patient-derived tumor organoids, along with gene-expression data and somatic variant calls. Quality control, raw/processed data, and scripts for genomic analyses are provided.\"},{\"question\":\"Which neuroendocrine tumor types and sample sizes are covered?\",\"answer\":\"The dataset covers rare pulmonary neuroendocrine tumors (n = 12), ileal neuroendocrine tumors (n = 6), and large-cell neuroendocrine carcinoma (n = 5). It also includes matched parental samples for the majority of samples and longitudinal PDTO sampling across time points.\"},{\"question\":\"How are variants detected in tumor-only RNA-seq?\",\"answer\":\"The document describes using WGS somatic calls to train a random forest classifier to detect variants in tumor-only RNA-seq. Histopathology images used for medical diagnosis are also reported.\"}]","Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms - Data Note | PDF",1790039793,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/819d78165f8113d322f0b34e24f1043a.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4c2512697d6cdd5fc359aa0b3609dfc.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce84290719d06bc068ff8f49632daf22.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ef3e3aaffa9c2eb941cd08cd04196ff.webp",980,1287]